21st.BIO

Merry Christmas and happy holidays from our labs ❄   2024 has been incredible for us at 21st.BIO. As we reflect on the year gone by, we're so grateful for the collaborations with our new and established partners. Thank you for choosing us to be part of your journey.   With too many accomplishments to be listed, we are particularly proud of… 🧬 Our team's new scientific breakthroughs in strain engineering. 🛠️ The opening of our pilot plant facility in our Danish headquarters. 📜 Our regulatory approval for all of our customers to commercialize BLG essential+™ in the USA. 🤝 The onboarding of so many of you in development programs or dedicated projects. 📈 Our customers' progress towards large-scale manufacturing at an attractive cost.   We’re just getting started… Cheers to a new year of pushing boundaries together.

We're looking for a (wo)man in finance 📈 Our team is hiring for two positions, based in our Copenhagen headquarters. Is this you? ▶️ A Senior Finance Controller with 5+ years of relevant experience. Key responsibilities include: overseeing balance sheet and P&L controlling, leading account preparations, financial reporting processes, analyzing operational costs and projects, enhancing finance tools and processes, including BI reporting, supporting finance model maintenance and managing cash flow... ▶️ A Finance Operations Associate and future master of Business Central. Key responsibilities include: accounting, financial controlling, payroll admin... Why work with us? ☑️ 21st.BIO is fueled by a bold mission. We help people who change the world with our cutting-edge precision fermentation technology – preparing the future of sustainable food, nutrition, agriculture, and materials. ☑️ We all make it happen. Our Science, Commercial and Operations teams work as one and recognize everyone's importance. Grow your career in a company that values innovation and purpose, and its people. ☑️ Work in an international setup across Denmark and California, with colleagues from all over the world. Explore the roles and apply: https://21st.bio/career/ #Hiring #Finance #Biotechnology

Idle time? Not here ❌ Since its inauguration in May, our pilot plant has not seen a single week of inactivity.   Dairy proteins, spider silk, molecules for agriculture, proteins used in biomining… You name it, we brew it.   Located in our headquarters in greater Copenhagen, our pilot facility is designed as a full industrial production setup, just downscaled into a pilot plant. This is how we best help companies in their production upscaling: optimizing USP and DSP processes to ensure production in larger volumes will run smooth.   There are many pilots out here – so what's different with us? 📈 Data and IP: It's all yours, exactly as it should be. Enjoy full data access during and after your run. 🛠️ Mini factory setup: Featuring the latest equipment from trusted brands – just like what you'll find at larger scales. Designed to prepare you for industrial production. 🧬 Strain Engineering: Looking to boost your productivity? Our strain experts are here to make it happen. 🤝 We get it: We're more than just steel. Our own projects face the same upscaling challenges, and we bring this hard-earned experience to the table.   Almost fully booked until March! We’ve got a few spots left – secure your pilot capacity for 2025 now: https://lnkd.in/drhPtVub   #Bioproduction #Biotech #Biomanufacturing

Our co-founder and CEO Thomas G. Schmidt was on stage last week for the tenth edition of Gulfood Manufacturing FoodTech Summit in Dubai.   With his extensive expertise, Thomas was invited to join the panel discussion, ‘Exploring Innovations and Investments in Alternative Proteins’, where he shared valuable insights and guidance.   Here are some takeaways:   🌍 The world needs a sustainable way to feed the growing and ageing population: the UN warns us that this means doubling our food – and protein – production. Conventional agriculture will not be able to keep up with this demand, but precision fermentation can help close this protein gap. Precision fermentation can power food resilience and self-sufficiency, especially significant for Middle Eastern countries with limited arable land and water supply.   📈 For this, we need the technology to get to industrial scale. Three parameters are key to scale biomanufacturing: demand, strains, and scale. The demand is here for certain. Few strains can thrive in large-scale fermentation environments and produce large quantities of product: 21st.BIO offers experience. To scale, we will need to build mega facilities dedicated to protein production. 🥛 Not all proteins are created equal. With the best nutritional profile and functionalities, we've trained our microbes to produce milk proteins in their purest form. No lactose, antibiotics, cholesterol, or fat – just pure protein. 🌟 BLG essential+™ is easy to include in all types of products, from alternative or hybrid dairy products, sports food and clear beverages, to tailored nutritional solutions for seniors or patients under GLP-1 medication.   🥇 21st.BIO develops the most advanced strains, which can remain proficient in large-scale fermentation – inherited out of a license from Novonesis. Working with the best strain, fermentation and biomanufacturing experts, we support customers with proteins for nutrition and food, but also agriculture, biomaterials, and even biomining. Our long track of experience considerably derisks product development.   That’s what we offer at 21st.BIO: industrially proven production technology for high-quality proteins. #AltProteins #Biomanufacturing #FutureFood

The past weeks have been a non-stop ride for 21st.BIO. Meeting with the FAO, participation in conferences, customers visits, new partnerships… We are moving at full speed to drive forward sustainable protein production at scale, and help build a more resilient food system globally. 🌍   Our colleague José Arnau, Director Strain Development & Regulatory Affairs, attended FoodRevolution 2024 in Parma. José was invited to present the precious role of precision fermentation in driving both the food revolution and the green transition, and the remaining challenges on the way. Beyond technological advances and improvements, we need to be able to get products to market. And market approval in Europe is too slow. He highlighted the importance of collaboration and open dialogue with governments and regulatory bodies for this to improve. "If we all help," the future of food can be more nutritious, healthy, and sustainable.   Per Falholt, our co-founder and CSO, and Philippe Gaudin, Fermentation Director, were at ESBES and the FBM Symposium in Copenhagen. Per was on stage to share his leading experience in upscaling precision fermentation protein production to large volumes, for food and materials proteins. The audience was interested to hear concrete examples of our work for customers, upscaling the production of milk protein beta-lactoglobulin, and spider silk proteins.   Barbara Taudorf Andersen, Director Commercial Development and Strategic Partnerships, gave an opening speech to visionary leaders of the food industry at the Food Strategy Associates (FSA) event on the future of food in London. Based on her experience with technology and business model disruption in the financial and energy industries, she shared the perspective that the transformation needed to make the food system sustainable in terms of supply and footprint is more fundamental that many of the other technological transformations we are looking at in other industries. Precision fermentation can play an instrumental role in enabling large scale, sustainable, distributed production in all parts of the world.    Henrik M. Geertz-Hansen, Director of Customer Engagement and R&D Operations, was invited to join the FAO meeting on cell-based foods and precision fermentation, in Toronto. 65 participants from biotech companies, academic institutions and regulators were present to discuss the challenges and opportunities of these technologies for food production. Henrik was able to share our advances in precision fermentation, highlighting the benefits of our production technology to produce food at industrial scale. As the precision fermentation launchpad, we develop the technology and make it accessible to all food players to scale the production of nutritious and sustainable ingredients.   We are incredibly inspired by all these conversations, and look forward to taking even more innovations from vision to reality.

This Wednesday, our co-founder and CSO Per Falholt and our colleague Barbara Taudorf Andersen joined key players of the Danish and European biosolutions scene for the second Biosolutions summit.   This event was a manifestation of the potential of biosolutions, and of the companies redefining the biotech industry in Denmark.   Mads Krogsgaard Thomsen, CEO at the Novo Nordisk Foundation, and Ester Baiget, CEO at Novonesis, lead the way stating that:   💶 It is time to subsidize the future – instead of subsidizing the past. We have the experience: to get new solutions to market, they need support. Especially when the competing solutions are subsidized.   🍀 Sustainable solutions (i.e products produced with biology) are competitive – when the hidden cost of traditional animal-based products is taken into account.   It was great to hear Arla Foods state that the future can't be animal production vs. alternative sources. To feed the growing population, we need both.   Danish Minister for Industry, Business, and Financial Affairs, Morten Bødskov, clearly stated that structural changes are needed to create a European home market.   Our co-founder and CSO Per Falholt presented 21st.BIO's work and shared important takeaways: ▶ There is a black swan coming towards our global food systems. The growing and ageing population needs more nutritious food, and current production is capped. ▶ Biosolutions are being scaled already and can redefine the capabilities of all regions to reach self-sufficiency. ▶ Europe owns the leading technology – but we will fall behind if we do not establish large scale manufacturing of protein in Denmark and other EU countries, as well as fast-track 3-5 proteins to get these products to market in Europe.   Many thanks to the European Biosolutions Coalition, DI Bio, the Alliance for Biosolutions, and Sofie Carsten Nielsen for the organization and support. Thank you all for the inspiring discussions and presentations. 

Meet our co-founder and CEO Thomas G. Schmidt and our colleague Barbara Taudorf Andersen, Director Commercial Development and Strategic Partnerships, at the upcoming Gulfood Manufacturing FoodTech Summit next week in Dubai.   🗓 Mark your calendars: on Wednesday 6th November, at 14:50, Thomas will be part of the panel discussion "Exploring innovations and investments in alternative proteins".   With over 2,500 exhibitors from 72 countries, Gulfood Manufacturing is a reference for food and beverages manufacturers globally. As the food industry is facing unprecedented challenges — climate change impact on yields, soaring raw materials costs, supply chain disruptions, unrelenting sustainability demands — new technologies are needed for a more secure, resilient, and nutritious food supply.   We at 21st.BIO are building the first concrete platform for sustainable food production at scale, powered by precision fermentation.   The panel discussion is an opportunity to hear Thomas G. Schmidt sharing knowledge and advice on: ➡ How we can use precision fermentation to close the protein gap. ➡ His perspective on the future of precision fermentation in production of high-quality nutrition. ➡ Production upscaling strategies to reach industrial production of proteins. Planning to attend? Reach out already and book a meeting with Barbara Taudorf Andersen and Thomas G. Schmidt. 

We're very proud to make the cover of Berlingske Business, sharing that precision fermentation can be the key to secure food and climate resilience 📰   In the article, our CEO Thomas G. Schmidt explains that it is time to add another production technology to produce foods and materials for the world. A clean, green, resilient, efficient, consistent, and fast-paced solution is ready to take over: precision fermentation.   Denmark and Europe should leverage their world-leading position in precision fermentation and establish large scale manufacturing capacity in Denmark to produce nutritious proteins. Cow's milk proteins provide an unmatched balance of complete nutrition, functional benefits, and versatility. With 21st.BIO's production technology food manufacturers across the globe, are now able to produce these proteins – using precision fermentation technology instead of cows.   Precision fermentation technology is a Danish pride, fueling the global successes of Novo Nordisk and Novonesis. Building on this legacy, 21st.BIO is now developing the technology for new areas of application: nutritious foods, agriculture, biomaterials, and even biomining.   For this, huge production volumes are required. That's why we need mega production facilities to be built – ideally, in Europe, where we have the leading technology.   "Denmark has a unique ecosystem for large-scale biomanufacturing. We have the technology, the knowledge, and the skilled people who know how to put it together. Protein manufacturing could easily be our next wind turbine adventure. But there are plenty of headwinds in Denmark, and that's unfortunate," Thomas told Berlingske.   Our customers are already upscaling their production of the amazing whey protein, beta-lactoglobulin (BLG). Our production technology, BLG Essential+™, has already been approved in the USA. But it will take many years until you can find it in European products... While many biosolutions leaders are based in Europe, the EU legislators are too slow to adapt.   The EU and Denmark may be missing an opportunity as other countries ramp up their investments. It's not too late to take a U-turn and change the game to secure that Europe can leverage financially on this technology advancement.   "But if it's going to happen, we have to decide on it. A full-scale protein factory in Denmark will probably be a bit more expensive than if we built it in other countries and will require some government support. But if we build the first few, then they can be copied, and we will be able to sell hundreds around the world." Many thanks to Vibeke Lyngklip Svansø for this great piece.   Read the full article here: https://lnkd.in/d3XZUfSp   #EU #Food #Biotech

We're in the news again 📰 Our CEO Thomas G. Schmidt talked about the role of precision fermentation in the future of food, and how Denmark as a country may miss an opportunity in the field as other countries ramp up their investments.   Precision fermentation is a powerful technology with gigantic potential. While many precision fermentation companies emerge and develop in Europe, their success stories often mean a relocation across the Atlantic to the USA.   The USA, among other countries, invest heavily in precision fermentation as part of their security and self-sufficiency policies. They recognize the strategic importance of precision fermentation technology to secure future supply in nutritious food, materials, and agriculture.   The European Union and Denmark must work harder to stay competitive in a changing environment.   There's lots of work to be done to get there, and we're not shying away from it. At 21st.BIO, we're taking our part, developing the most advanced precision fermentation technology and making it accessible and affordable for all industry players. With our pilot plant fully operational, we help our customers upscale their production towards commercially-relevant levels.   But that won't be enough to feed the world. We will need many industrial-scale production facilities. And for this, we need the EU and Danish governments to: ➡ Change agricultural subsidies to favor new production technologies. ➡ Collaborate with the farmers organizations to ensure a transition towards a new production model ➡ Speed up regulatory approval to allow Europeans access to high quality nutrition and ensure self-sufficient supply in EU ➡ Establish a first mega protein factory in Denmark, securing strategic food supply and job opportunities.   Thank you to Sjællandske Medier and Anders Rostgaard Birkmann for visiting us and showcasing our story. #Biotech #Biomanufacturing #Sustainability

Meet us at CPHI! Our colleague Rasmus Rune Hansen, Director of Client Development and Project Management, is on the ground in Milan, eager to connect with industry innovators interested in precision fermentation.   At 21st.BIO, we empower our customers with the world-leading precision fermentation tech, know-how, and expertise needed to produce top-quality nutraceuticals and compounds for pharmaceutical applications, at an industrial scale for competitive pricing.   Precision fermentation is gaining attention for its sustainability, supply chain security, enhanced product consistency, animal-free production, customizability, reduced resource use, and innovative ingredient development. Imagine leveraging our strains and technology to produce...  ☑ A truly vegan collagen with the same structure and benefits as animal-sourced molecules ☑ The dairy proteins beta-lactoglobulin (the main whey protein) and caseins, offering versatile applications thanks to their both nutritious and functional properties ☑ Growth factors tailored for pharma applications ☑ ... or any protein of interest to you.   Whether you're interested in nutraceuticals or pharma compounds, connect with Rasmus to explore how we can help turn your ingredient vision into reality.   #PrecisionFermentation #Nutraceuticals #Pharma